MTOR and hepatocellular carcinoma: Beyond gene mutations, aberrant signaling in pathways such as Wnt1/β-catenin, protein kinase B (Akt)/mechanistic target of rapamycin (mTOR), and mitogen-activated protein kinase (MAPK) contributes to cell cycle deregulation in HCC [22].